Select Page


Expanding MAT in County Criminal Justice Settings:
A Learning Collaborative:
A Joint Effort of the California Department of Health Care Services Medication Assisted Treatment Expansion Project and Health Management Associates
Download ApplicationDownload Program Description

COHORT 2 Participation at a Glance

Who is eligible to participate?

The second cohort of this technical assistance program is available to teams from all California Counties interested in developing or expanding access to Medication Assisted Treatment (MAT) for opioid addiction in their jails and through their drug court systems (if applicable). Teams will begin at different points in access to MAT and need not end at the same point. However, teams must demonstrate interest in expanding access to at least two forms of MAT for opioid use disorder (naltrexone, methadone, buprenorphine) in order to be eligible.

Funding to County Teams

Each County Team will receive up to $25,000 across the project period. These funds may be used to offset team travel expenses to the Learning Collaboratives, participate in other training to develop the capacity to provide MAT in criminal justice, off-set compensation for the Team Champion or other team members, and to cover other approved expenses.

Pending federal approval, additional grants of $100,000 – $300,000 maybe made available to participating counties to expedite implementation of SUD screening, assessment, treatment, and MAT while local sustainable funds are secured. A short application will be required.

How does a team apply to participate?

The application is simple. Download it here. Follow the instructions and refer to the guidance in the program description. Submit completed applications and letters of support 5 pm PT on Friday , March 1, 2019.

Where can I find more information?

A recording and slides from informational webinar about the project can be found here

Have Questions?

From participation eligibility and requirements to program structure and support, you’ll find answers to your questions here.

Still have questions or want to talk? Contact us at: